ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
118.84
1.64
( 1.40% )
Actualizado: 11:49:09

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
118.84
Postura de Compra
118.84
Postura de Venta
118.85
Volume Operado de la Acción
1,829,815
116.45 Rango del Día 119.04
99.26 Rango de 52 semanas 123.58
Capitalización de Mercado [m]
Precio Anterior
117.20
Precio de Apertura
116.47
Última hora de negociación
11:49:05
Volumen financiero
US$ 215,632,755
Precio Promedio Ponderado
117.844
Volumen promedio (3 m)
2,395,314
Acciones en circulación
159,600,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
6.50
Beneficio por acción (BPA)
18.28
turnover
371.5M
Beneficio neto
2.92B

Acerca de iShares MSCI ACWI

The investment seeks to track the investment results of the MSCI ACWI composed of large- and mid-capitalization developed and emerging market equities. The fund generally will invest at least 90% of its assets in the component securities of the underlying index and in investments that have economic ... The investment seeks to track the investment results of the MSCI ACWI composed of large- and mid-capitalization developed and emerging market equities. The fund generally will invest at least 90% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization index designed to measure the combined equity market performance of developed and emerging markets countries. Mostrar más

Sector
Mgmt Invt Offices, Open-end
Industria
Mgmt Invt Offices, Open-end
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
iShares MSCI ACWI is listed in the Mgmt Invt Offices, Open-end sector of the NASDAQ with ticker ACWI. The last closing price for iShares MSCI ACWI was US$117.20. Over the last year, iShares MSCI ACWI shares have traded in a share price range of US$ 99.26 to US$ 123.58.

iShares MSCI ACWI currently has 159,600,000 shares in issue. The market capitalisation of iShares MSCI ACWI is US$18.71 billion. iShares MSCI ACWI has a price to earnings ratio (PE ratio) of 6.50.

ACWI Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-3.66-2.98775510204122.5122.58116.3556108940120.07682172SP
4-1.28-1.0656010656120.12123.58116.3553168878121.09848481SP
12-1.46-1.2136325852120.3123.58116.3552395314120.13403161SP
265.865.18675871836112.98123.58105.312476951116.50062161SP
5217.8117.6284271998101.03123.5899.263019014110.16038395SP
15617.2616.9915337665101.58123.5875.71383388996.62692751SP
26039.8350.411340336779.01123.5853.31374506292.42764584SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 5.08
(276.30%)
109.18M
EDBLEdible Garden AG Inc
US$ 0.3871
(166.23%)
171.09M
HSDTHelius Medical Technologies Inc
US$ 0.83996
(74.99%)
107.32M
APTOAptose Biosciences Inc
US$ 0.2745
(61.28%)
280.2M
OPTXSyntec Optics Holdings Inc
US$ 2.97
(53.09%)
26.41M
CYNCYNGN Inc
US$ 0.4114
(-74.45%)
19.44M
MTEMMolecular Templates Inc
US$ 0.1427
(-59.23%)
6.18M
PRFXPainReform Ltd
US$ 4.96
(-55.56%)
2.08M
GALTGalectin Therapeutics Inc
US$ 0.90
(-55.00%)
6.58M
FNGRFingerMotion Inc
US$ 1.239
(-38.05%)
2.33M
APTOAptose Biosciences Inc
US$ 0.2745
(61.28%)
281.34M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.63
(10.53%)
199.74M
EDBLEdible Garden AG Inc
US$ 0.3871
(166.23%)
171.1M
RGTIRigetti Computing Inc
US$ 9.6899
(29.72%)
149.82M
NVDANVIDIA Corporation
US$ 135.1702
(3.44%)
137.14M
wshaw14 wshaw14 5 minutos hace
https://www.msn.com/en-us/money/other/energy-transfer-subsidiary-signs-20-year-lng-supply-deal-with-chevron/ar-AA1weN9H?ocid=BingNewsVerp
ET
rodman rodman 5 minutos hace
Hopefully RFK and DOGE can rid the FDA of its in-efficiency and corruption that has been pervasive in the pharmaceutical industry for years! In the meantime here we are!
https://www.greenlight.guru/blog/fda-medical-device-approval-process
$5-$10+
UEEC
RobotDroid RobotDroid 5 minutos hace
The thing everyone is missing is how many mistakes are in the bloated 1.7 million pages. Obviously many. LPoop screwed the submission up, thus the silence
NWBO
NoMoDo NoMoDo 5 minutos hace
That is him. Now... for the bonus round... where have we seen him before?
HMBL
Techroemancer Techroemancer 5 minutos hace
You mean when he got hired on to test if the product is able to be safely applied to skin? Lmao. Too easy to refute your wild conspiracies.
MGON
lizzy241 lizzy241 5 minutos hace
Sleven, the formulary for CVS Caremark shows Vascepa at tier 2. In 2024, it was tier 3. I found the below on page 30 of their formulary. Why the discrepancy?

SOAJ 140mg/ml
2 NM PA
VASCEPA CAPS .5gm, 1gm 2
VYTORIN TAB 10-10MG
QL (30 tabs / 30 days)
CVS
Steady_T Steady_T 5 minutos hace
That is a reasonable approach. Less risk/less reward.

If history is a guide there will be a big move up on approval and then a beat down by the mysterious forces on the market.
There may not be a beat down if approval is followed up by additional news.

I certainl
AVXL
gdl gdl 5 minutos hace
Nasdaq, S&P, Dow soar 2% each as soft inflation data helps overcome Fed 'overreaction

Yup over reaction. Like Trumps Chaos. Like a Pandemic. Like current valuations.

Bubblegum delicious. Trump can’t wait till January 20th to start his dictionary reign. I love his
blackhawks blackhawks 5 minutos hace
Who's a good boy?

https://x.com/AmoneyResists/status/1870002702257926399
linkvest linkvest 5 minutos hace
I grabbed some 13s but these 14s looks so cute not to have a few.
RDAR
budfoxfun budfoxfun 5 minutos hace
$SGTM Aired on Fox Business https://finance.yahoo.com/news/street-show-617-airs-tonight-035500854.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
SGTM
ATVrider ATVrider 5 minutos hace
I’ve got 200 at $44 and 100 under $40. My first buy was at $8,5 but sold too soon at $30. I am sure we have bottomed out but we shall see ! I am ready for triple digits aswell !
NUKK
XMaster2023 XMaster2023 6 minutos hace
Yes many shorts and paid posters employed by the market makers and/or BP that have many eyes and no brain.
NWBO
Banjo50 Banjo50 6 minutos hace
I think it should be five cents. I bid five cents EACH FOR 1,000 SHARES!!!
ME
Lone Clone Lone Clone 6 minutos hace
Colibri and Partne Tocvanr to Begin Diamond Drilling at Pilar, Closes Financing

https://www.newsfilecorp.com/release/234656/Colibri-and-Partner-to-Begin-Diamond-Drilling-at-Pilar-and-Closes-Financing

December 20, 2024 8:25 AM EST | Source: Colibri Resource Corporation
linkvest linkvest 6 minutos hace
This would make your RDAR stand out in your stock portfolio Gregg... Big numbers are always easier to see. Only about 14 million left of the 14s. Easy peasy
RDAR
Jahvik Jahvik 6 minutos hace
Is this him?

https://orenlitwinlaw.com/

HMBL
martyDg martyDg 7 minutos hace
The data you gathered doesn't tell you you're right. lol. again, your arrogance about being correct because of your data will put you to the right place. Merck did not say who it's for and you don't work for them. You need to have some DOUBTS sometimes Overconfidence will do no good to you.
NWBO
RIGATONI RIGATONI 7 minutos hace
.0014 hits, the DTC numbers working out nicely again with what was added recently. Looking great, like to see north of 100M volume again ~Rig
DTC
TURCH TURCH 7 minutos hace
Headed back there IMO


Regards
ASKH
attilathehunt attilathehunt 7 minutos hace
If Merck is truly spending billions on the buildout then surely a deal is worked out predicated on approval.

If such is the xcase, then there will not be a bidding war, since Merck most likely wrapped up the science with NWBO and they are waiting for approval as we are.
NWBO
blackhawks blackhawks 7 minutos hace
Who's a good boy?

https://x.com/AmoneyResists/status/1870002702257926399
Timing101 Timing101 7 minutos hace
$APCX Back on the move today. HOWEVER, What folks need to know are about the Technology and Patents APPTECH ($APCX) have , with Proprietary Intellectual Property in the Market . They are being used by companies such as PAYTOME, the #2 rated start up (see link below , I always supply) in the AI
APCX

Su Consulta Reciente

Delayed Upgrade Clock